Skip to content
CACA·WikiThe living current-affairs record
--:--:--to drop
Sign in
Science & Technologyv1 · 1 version

Qdenga — India's First Dengue Vaccine

India cleared its first dengue vaccine on 21 July 2026 when the drug regulator CDSCO granted marketing authorisation to Qdenga, a live, attenuated tetravalent shot made by Takeda of Germany and cleared for people aged 4 to 60. It is the country's first approved vaccine for preventing dengue, given as two doses three months apart, and already sells in 42 countries with WHO prequalification.

Last updated 23 July 20265 min read
Latest update
India's drug regulator CDSCO has approved Qdenga, the country's first dengue vaccine, for people aged 4 to 60 — a live attenuated tetravalent shot already cleared in 42 countries with WHO prequalification.

Read the full living note — free

The complete note in both exam lenses (UPSC analytical / fact capsule), its full version history, and “what changed since you last read” — plus tonight's quiz.

Open in CA·Wiki

AI-assisted, human-reviewed · sourced from PIB, RBI & ministries · editorial policy

More living notes in Science & Technology

Browse all topics →

Qdenga — India's First Dengue Vaccine — Science & Technology current affairs | CA·Wiki